Affimed ties with Roche in cancer immunotherapies deal

29th August 2018 Uncategorised 0

Shares in Affimed more than doubled on news that it has signed a deal with Roche group Genentech to develop immunotherapies for various cancers.

More: Affimed ties with Roche in cancer immunotherapies deal
Source: News